Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia
Positive response to PD-1/PD-L1 blockades was observed in the treatment of solid tumors. However, the clinical response to PD-1/PD-L1 blockade varied in patients with acute myeloid leukemia (AML). It is thought that there are factors other than PD-1 and PD-L1 that may affect the effect of immunother...
Saved in:
Main Authors: | Cunte Chen (Author), Ling Xu (Author), Rili Gao (Author), Shunqing Wang (Author), Yuping Zhang (Author), Caixia Wang (Author), Chengwu Zeng (Author), Yangqiu Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is There a Place for PD-1-PD-L Blockade in Acute Myeloid Leukemia?
by: Laura Jimbu, et al.
Published: (2021) -
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma
by: Cunte Chen, et al.
Published: (2022) -
BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1
by: Songnan Sui, et al.
Published: (2024) -
The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10-IL-10R Pathways in Acute Myeloid Leukemia
by: Laura Jimbu, et al.
Published: (2021) -
Genetic polymorphism and immunological evaluation of PD-1 in Iraqi patients with acute myeloid leukemia
by: Aseel S. Mahmood
Published: (2024)